Acute and chronic vascular rejection in nonhuman primate kidney transplantation

American Journal of Transplantation

Volumn 6, Issue 6, 2006, Pages 1285-1296

  Wieczorek, G ^a   Bigaud, M ^a   Menninger, K ^a   Riesen, S ^a   Quesniaux, V ^a,b   Schuurman, H J ^a,c   Audet, M ^d   Blancher, A ^e   Mihatsch, M J ^f   Nickeleit, V ^g  

^a NOVARTIS PHARMA AG   (Switzerland)

^b CNRS   (France)

^c Immerge Biotherapeutics Inc   (United States)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e CHU RANGUEIL   (France)

^f UNIVERSITY HOSPITAL BASEL   (Switzerland)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Allograft rejection; Immunohistochemistry; Kidney transplantation; Nonhuman primate; Vascular rejection

Indexed keywords

CD3 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; CYCLOSPORIN A; FIBRONECTIN; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE SODIUM SUCCINATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA; ARTICLE; BRONCHOPNEUMONIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENDARTERITIS; FEMALE; GLOMERULOPATHY; GRAFT FAILURE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTOXICITY; INFECTION COMPLICATION; INFLAMMATORY CELL; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MACROPHAGE; MALE; MYOFIBROBLAST; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PYELONEPHRITIS; T LYMPHOCYTE; VASCULAR GRAFT REJECTION;

ACUTE DISEASE; ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; ENDARTERITIS; FEMALE; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MACACA FASCICULARIS; MALE; POSTOPERATIVE PERIOD; PRIMATES; SURVIVAL ANALYSIS; VASCULAR DISEASES;

EID: 33745820369     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01307.x     Document Type: Article

References (36)

1. Jindal RM, Hariharan S. Chronic rejection in kidney transplants: An in-depth review. Nephron 1999; 83: 13-24.
2. Monaco AP, Burke JF Jr, Ferguson RM et al. Current thinking on chronic renal allograft rejection: Issues, concerns and recommendations from a 1997 roundtable discussion. Am J Kidney Dis 1999; 33: 150-160.
3. Ivanyi B. Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection. Nephrol Dial Transplant 2003; 18: 655-660.
4. Mihatsch MJ, Nickeleit V, Gudat F. Morphologic criteria of chronic renal allograft rejection. Transplant Proc 1999; 31: 1295-1297.
5. Haas M, Kraus ES, Samaniego-Picota M, Racusen LC, Ni W, Eustace JA. Acute renal allograft rejection with intimai arteritis: Histologic predictors of response to therapy and graft survival. Kidney Int 2002; 61: 1516-1526.
6. Tejani A, Ho PL, Emmet L, Stablein DM. Reduction in acute rejections decreases chronic rejection graft failure in children: A report of the North American Pediatric Renal Transplant Cooperative Study. Am J Transplant 2002; 2: 142-147.
7. Nickeleit V, Vamvakas EC, Pascual M, Poletti BJ, Colvin RB. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998; 9: 1301-1308.
8. Gaber LW, Moore LW, Gaber AO, Tesi RJ, Meyer J, Schroeder TJ. Correlation of histology to clinical rejection reversal: A thymoglobulin multicenter trial report. Kidney Int 1999; 55: 2415-2422.
9. Ward MR, Pastercamp G, Yeung AC, Borst C. Arterial remodeling. Mechanisms and clinical implications. Circulation 2000; 102: 1186-1191.
10. Schwarz A, Gwinner W, Hiss M, Radermacher J, Mengel M, Haller H. Safety and adequacy of renal transplant protocol biopsies. Am J Transplant 2005; 5: 1992-1996.
11. Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
12. Schuurman HJ, Kuhn EM, Jonker M. Chronic rejection in rhesus monkey kidney allografts. Transplant Proc 1997; 29: 2546-2547.
13. Socha WW, Blancher A, Moor-Jankowski J. Red cell polymorphism in nonhuman primates, a review. J Med Primatol 1995; 24: 282-305.
14. Bigaud M, Maurer C, Vedrine C, Puissant B, Blancher A. A simple method to optimize peripheral blood mononuclear cell preparation from cynomolgus monkeys and improve mixed lymphocyte reactions. J Pharmacol Toxicol Method 2004; 50: 153-159.
15. Gaschen L, Kunkler A, Menninger K, Schuurman HJ. Safety of percutaneous ultrasound-guided biopsy of renal allografts in the cynomolgus monkey: results of 348 consecutive biopsies. Vet Radiol Ultrasound 2001; 42: 259-264.
16. Schuurman HJ, Slingerland W, Mennninger K et al. Pharmacokinetics of cyclosporine in monkeys after oral and intramuscular administration: Relation to efficacy in kidney allografting. Transplant Int 2001; 14: 320-328.
17. Gaschen L, Schuurman HJ. Renal allograft vasculopathy: Ultrasound findings in a non-human primate model of chronic rejection. Brit J Radiol 2001; 74: 411-419.
18. Nickeleit V, Zeiler M, Gudat F, Thiel G, Mihatsch MJ. Detection of the complement degradation product C4d in renal allografts: Diagnostic and therapeutic implications. J Am Soc Nephrol 2002; 13: 242-251.
19. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 2003; 18: 2232-2239.
20. Thiru S. In: Rejection reaction. Pathology and Immunology of Transplantation and Rejection. Thiru S and Waldmann H eds. Oxford: Blackwell Science Ltd, 2001, pp. 215-231.
21. Kirk AD. Crossing the bridge: large animal models in translational transplantation research. Immunol Rev 2003; 196: 176-196.
22. Mauiyyedi S, Pelle PD, Saidman S et al. Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries. J Am Soc Nephrol 2001; 12: 574-582.
23. Jabs WJ, Sedlmeyer A, Ramassar V et al. Heterogeneity in the evolution and mechanisms of the lesions of kidney allograft rejection in mice. Am J Transplant 2003; 3: 1501-1509.
24. Herrero-Fresneda I, Torras J, Cruzado JM et al. Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol 2003; 162: 127-137.
25. Thomas JM, Carver M, Scott J, Williams E, Thomas F. Effect of rabbit anti-human thymocyte globulin on lymphocyte subpopulations and functions following allotransplantation in the rhesus monkey. Transplantation 1979; 27: 163-170.
26. Preville X, Flacher M, LeMauff B et al. Mechanism involved in anti-thymocyte globulin immunosuppressive activity in a nonhuman primate model. Transplantation 2001; 71: 460-468.
27. Badid C, Mounier N, Costa AM, Desmouliere A. Role of myofibroblasts during normal tissue repair and excessive scarring: Interest of their assessment in nephropathies. Histol Histopathol 2000; 15: 269-280.
28. Pedagogos E, Hewitson TD, Walker RG, Nicholis KM, Becker GJ. Myofibroblast involvement in chronic transplant rejection. Transplantation 1997; 64: 1192-1197.
29. Serini G, Bochaton-Piallat ML, Ropraz P et al. The fibronectin domain ED-A is crucial for myofibroblastic phenotype induction by transforming growth factor-beta1. J Cell Biol 1998; 142: 873-881.
30. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999; 21: 658-665.
31. Grimm PC, Nickerson P, Jeffery J et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001; 345: 93-97.
32. Wu GD, Nolta JA, Jin YS et al. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 2003; 75: 679-685.
33. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-7562.
34. Quan TE, Cowper S, Wu SP, Bockenstedt LK, Bucala R. Circulating fibrocytes: Collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36: 598-606.
35. Sartore S, Chiavegato A, Faggin E et al. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res 2001; 89: 1111-1121.
36. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-2380.